The website for professionals in Laboratory Medicine

First end-to-end safe needle destruction technology

A recent survey showed that 94% of practising surgeons in the UK have either been personally affected by a needlestick injury (NSI) or have seen a colleague experience one.

The Royal College of Nursing also reported last year that the pressures of the pandemic and lack of training accounted for a 50% rise in sharps injuries. 

UK-based smart med-tech innovator NeedleSmart aims to change this statistic.  NeedleSmart has designed the world’s first end-to-end vaccination and safe needle destruction system aimed at reducing the 100,000 needlestick injuries (NSI) to NHS workers in the UK each year and three million globally.

Of the 100,000 reported cases of NSI, NHS healthcare workers in the UK are the most affected profession, with 500,000 NSI in Germany and more than one million NSI in the USA. They are estimated to cost each NHS trust £500,000 each year and an estimated £127 million across England. This is not to mention the impact it has on staff absenteeism, the cost of bringing in replacement staff and legal litigation to NHS trusts, which are already under increased pressure with the pandemic.

To achieve this, the Knowsley-based MedTech disruptor havs entered into an exciting new innovation partnership with the Alder Hey Children’s NHS Foundation Trust, one of Europe’s leading paediatric healthcare institutions with a unique dedicated innovation centre focused on solving real world problems faced day to day. The first phase of that innovation partnership will work on a safety and NSI reduction programme as part of its clinician and patient safety enhancement. The project aims to impact, reduce and eventually prevent the 100,000 NSIs that occur every year to NHS healthcare staff.  

In its wider remit, NeedleSmart is also working with 15 NHS trusts across the UK as part of the nationwide pilot, where its focus is shared between safety enhancement, carbon reduction and sustainability.  This programme is breaking new ground on the art of the possible with regards to medical waste disposal resulting is direct carbon savings as part of the NHS sustainability initiative.

www.needlesmart.com

Upcoming Events

analytica 2022

Messe München, Germany
June 21-24, 2022

The Genomic and Microbiology Revolution: In Technology We Trust?

Royal Air Force Museum, Hendon, London
19 July 2022

Arab Lab Live 2022

Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022

Lab Innovations 2022

Hall 2 NEC, Birmingham
2 & 3 November 2022

MEDICA 2022

Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

analytica 2022

Messe München, Germany
June 21-24, 2022

The Genomic and Microbiology Revolution: In Technology We Trust?

Royal Air Force Museum, Hendon, London
19 July 2022

Arab Lab Live 2022

Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022

Lab Innovations 2022

Hall 2 NEC, Birmingham
2 & 3 November 2022

MEDICA 2022

Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025